You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 4, April 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Markers for Assessment of Nodal Metastasis in Laryngeal Carcinoma

Robert P. Takes, MD; Robert J. Baatenburg de Jong, MD, PhD; Ed Schuuring, PhD; Jo Hermans, PhD; André A. Vis; Sergey V. Litvinov, PhD; J. Han J. M. van Krieken, MD, PhD

Arch Otolaryngol Head Neck Surg. 1997;123(4):412-419.


Abstract

Background
Regional metastasis is an important factor in the treatment and prognosis of patients with head and neck squamous cell carcinoma. Although in recent years imaging techniques have improved, it is still impossible to detect small metastatic deposits. Metastasis is mainly determined by properties of the primary tumor and its interaction with surrounding structures.

Objective
To identify markers that predict the presence of metastasis based on the features of the primary tumor.

Design
Correlation of the results of histological, immunohistochemical, and molecular biological analysis with clinical and histopathological data.

Materials and Methods
Several histological features and biological markers were examined in 31 laryngeal carcinomas. The following markers were selected on their putative role in the process of metastasis and were studied using immunohistochemical and/or Southern blot techniques: proliferating cell nuclear antigen (PCNA),p53, retinoblastoma tumor-suppressor gene (Rb), myc, bcl-2 (inhibitor of apoptosis), epidermal growth factor (EGF), EGF-receptor (EGFR), neu, nm23 (also known as NME1, putative metastasis suppressor), desmoplakin, neuron cell-adhesion molecule (N-CAM), epithelial cell-adhesion molecule (Ep-CAM), E-cadherin, cyclin D1 (CCND1), and EMS1.

Results
The presence of an inflammatory reaction surrounding the tumor (P=.07), eosinophilic infiltration (P=.16), positive immunostaining for Rb (P=.02), negative immunostaining for Ep-CAM (P=.13), and amplification of CCND1 and EMS1 (P=.05) correlated with nodal metastasis. The combination of an inflammatory reaction, eosinophilic infiltration, and staining for Rb and Ep-CAM resulted in a superior accuracy in assessing nodal metastasis.

Conclusions
These results indicate that it is possible to predict and exclude lymph node metastasis by studying the features of the primary tumor only. When these results are confirmed in a larger series, biological markers may be powerful diagnostic tools with great impact on clinical decision making.

Arch Otolaryngol Head Neck Surg. 1997;123:412-419



Author Affiliations

From the Departments of Otolaryngology (Drs Takes and Baatenburg de Jong), Pathology (Drs Schuuring, Litvinov, and van Krieken and Mr Vis), and Biostatistics (Dr Hermans), University Hospital Leiden, Leiden, the Netherlands.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer
Gibcus et al.
Clin. Cancer Res. 2007;13:6257-6266.
ABSTRACT | FULL TEXT  

Amplification and Overexpression of CTTN (EMS1) Contribute to the Metastasis of Esophageal Squamous Cell Carcinoma by Promoting Cell Migration and Anoikis Resistance
Luo et al.
Cancer Res. 2006;66:11690-11699.
ABSTRACT | FULL TEXT  

Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas
Chung et al.
JCO 2006;24:4170-4176.
ABSTRACT | FULL TEXT  

Cisplatin-Induced Growth Arrest of Head and Neck Cancer Cells Correlates With Increased Expression of p16 and p53.
Yip et al.
Arch Otolaryngol Head Neck Surg 2006;132:317-326.
ABSTRACT | FULL TEXT  

Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture
Crist et al.
Carcinogenesis 2005;26:951-957.
ABSTRACT | FULL TEXT  

Molecular Staging of Cervical Lymph Nodes in Squamous Cell Carcinoma of the Head and Neck
Ferris et al.
Cancer Res. 2005;65:2147-2156.
ABSTRACT | FULL TEXT  

Epithelial Cell Adhesion Molecule (KSA) Expression: Pathobiology and Its Role as an Independent Predictor of Survival in Renal Cell Carcinoma
Seligson et al.
Clin. Cancer Res. 2004;10:2659-2669.
ABSTRACT | FULL TEXT  

Identification of Epithelial Cell Adhesion Molecule Autoantibody in Patients with Ovarian Cancer
Kim et al.
Clin. Cancer Res. 2003;9:4782-4791.
ABSTRACT | FULL TEXT  

Identification of Osteopontin as a Prognostic Plasma Marker for Head and Neck Squamous Cell Carcinomas
Le et al.
Clin. Cancer Res. 2003;9:59-67.
ABSTRACT | FULL TEXT  

Markers for Nodal Metastasis in Head and Neck Squamous Cell Cancer
Takes et al.
Arch Otolaryngol Head Neck Surg 2002;128:512-518.
ABSTRACT | FULL TEXT  

Antisense Inhibition of Cyclin D1 in Human Head and Neck Squamous Cell Carcinoma
Nakashima and Clayman
Arch Otolaryngol Head Neck Surg 2000;126:957-961.
ABSTRACT | FULL TEXT  

Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell-Cell Interactions Mediated by Classic Cadherins
Litvinov et al.
JCB 1997;139:1337-1348.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.